TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Healius Limited ( (AU:HLS) ) has provided an announcement.
Healius Limited announced the results of its Annual General Meeting, where all proposed resolutions were passed by a poll. Notably, the adoption of the 2025 Remuneration Report received over 75% approval, avoiding a second strike under the Corporations Act 2001, which meant that the Conditional Spill Resolution was not required. This outcome reflects positively on Healius’s governance and stakeholder relations, reinforcing its stable position in the healthcare industry.
The most recent analyst rating on (AU:HLS) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Healius Limited stock, see the AU:HLS Stock Forecast page.
More about Healius Limited
Healius Limited is a leading Australian healthcare company with over 30 years of experience, focusing on providing quality, affordable, and accessible healthcare services. The company operates a wide network of centers and employs over 8,000 people, offering specialty pathology services across Australia to both consumers and referring practitioners.
Average Trading Volume: 4,815,348
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$580.9M
For detailed information about HLS stock, go to TipRanks’ Stock Analysis page.